Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study.
Buysschaert I, Dubois CL, Dens J, Ormiston J, Worthley S, McClean D, Ottervanger JP, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky AJ, Bichalska M, Meis S, Verheye S. Buysschaert I, et al. Among authors: ormiston j. EuroIntervention. 2013 Sep;9(5):573-81. doi: 10.4244/EIJV9I5A93. EuroIntervention. 2013. PMID: 24058075 Free article. Clinical Trial.
9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study.
Verheye S, Agostoni P, Dubois CL, Dens J, Ormiston J, Worthley S, Trauthen B, Hasegawa T, Koo BK, Fitzgerald PJ, Mehran R, Lansky AJ. Verheye S, et al. Among authors: ormiston j. J Am Coll Cardiol. 2009 Mar 24;53(12):1031-9. doi: 10.1016/j.jacc.2008.12.012. J Am Coll Cardiol. 2009. PMID: 19298915 Free article. Clinical Trial.
First-in-human experience with the Medtronic Bifurcation Stent System.
Meredith IT, Worthley S, Whitbourn R, Webster M, Fitzgerald PJ, Ormiston J. Meredith IT, et al. Among authors: ormiston j. EuroIntervention. 2011 Oct 30;7(6):662-9. doi: 10.4244/EIJV7I6A108. EuroIntervention. 2011. PMID: 21959379 Free article. Clinical Trial.
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study.
Serruys PW, Garg S, Abizaid A, Ormiston J, Windecker S, Verheye S, Dubois C, Stewart J, Hauptmann KE, Schofer J, Stangl K, Witzenbichler B, Wiemer M, Barbato E, de Vries T, den Drijver AM, Otake H, Meredith L, Toyloy S, Fitzgerald P. Serruys PW, et al. Among authors: ormiston j. EuroIntervention. 2010 Jun;6(2):195-205. EuroIntervention. 2010. PMID: 20562069 Clinical Trial.
Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study.
Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Baldus S, Hauptmann KE, Suttorp MJ, Drzewiecki J, Pieper M, Schultheiss HP, Mauri L. Fajadet J, et al. Among authors: ormiston j. EuroIntervention. 2010 Nov;6(5):562-7. doi: 10.4244/EIJV6I5A95. EuroIntervention. 2010. PMID: 21044908
257 results